References
Guerrero-Molina MP, Bernabeu-Sanz Á, Ramos-González A, Morales-Conejo M, Delmiro A, Domínguez-González C, Arenas J, Martín MA, González de la Aleja J (2023) Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation. Neuroradiology. https://doi.org/10.1007/s00234-023-03263-1
Moosa A, Hughes EA (1974) Proceedings: L-glutamine therapy in Leigh’s encephalomyelopathy. Arch Dis Child 49(3):246. https://doi.org/10.1136/adc.49.3.246
Gagliardi D, Mauri E, Magri F, Velardo D, Meneri M, Abati E, Brusa R, Faravelli I, Piga D, Ronchi D, Triulzi F, Peverelli L, Sciacco M, Bresolin N, Comi GP, Corti S, Govoni A (2019) Can intestinal pseudo-obstruction drive recurrent stroke-like episodes in late-onset MELAS syndrome? A case report and review of the literature. Front Neurol 31(10):38. https://doi.org/10.3389/fneur.2019.00038
Fryer RH, Bain JM, De Vivo DC (2016) Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS): a case report and critical reappraisal of treatment options. Pediatr Neurol 56:59–61. https://doi.org/10.1016/j.pediatrneurol.2015.12.010
Funding
None received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethical approval
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Finsterer, J. Assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs. Neuroradiology 66, 459–460 (2024). https://doi.org/10.1007/s00234-024-03284-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-024-03284-4